<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Advances in medicine &#187; hepatitis С</title>
	<atom:link href="http://www.advances-in-medicine.com/category/hepatitis-%d1%81/feed" rel="self" type="application/rss+xml" />
	<link>http://www.advances-in-medicine.com</link>
	<description></description>
	<lastBuildDate>Thu, 02 Feb 2012 18:12:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Management of Recurrent Hepatitis C Following Liver Transplantation: Summary</title>
		<link>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-summary.html</link>
		<comments>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-summary.html#comments</comments>
		<pubDate>Wed, 18 Aug 2010 04:41:03 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[hepatitis С]]></category>
		<category><![CDATA[Hepatitis C virus]]></category>
		<category><![CDATA[immunosuppression]]></category>
		<category><![CDATA[interferon]]></category>
		<category><![CDATA[liver transplant]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[ribavirin]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=2014</guid>
		<description><![CDATA[Recurrent HCV is a major cause of allograft loss and mortality in liver transplant recipients with chronic HCV infection. The development of strategies designed to optimize patient and graft survival in this population is critical, as HCV is currently the most common indica­tion for liver transplantation. A greater understanding of the risk factors for progressive [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-summary.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Management of Recurrent Hepatitis C Following Liver Transplantation: Repeat Liver Transplantation</title>
		<link>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-repeat-liver-transplantation.html</link>
		<comments>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-repeat-liver-transplantation.html#comments</comments>
		<pubDate>Sun, 15 Aug 2010 00:24:02 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[hepatitis С]]></category>
		<category><![CDATA[Hepatitis C virus]]></category>
		<category><![CDATA[immunosuppression]]></category>
		<category><![CDATA[interferon]]></category>
		<category><![CDATA[liver transplant]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[ribavirin]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=2012</guid>
		<description><![CDATA[Ultimately, repeat liver transplantation may be considered in select patients with HCV recurrence and allograft fail­ure. Although prior data have identified HCV infection as an independent predictor of mortality following retrans- plantation, more recent reports have described similar rates of survival in HCV and non-HCV recipients. A key factor associated with the observed improvement in [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-repeat-liver-transplantation.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Management of Recurrent Hepatitis C Following Liver Transplantation: Immunosuppression</title>
		<link>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-immunosuppression.html</link>
		<comments>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-immunosuppression.html#comments</comments>
		<pubDate>Thu, 12 Aug 2010 22:29:01 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[hepatitis С]]></category>
		<category><![CDATA[Hepatitis C virus]]></category>
		<category><![CDATA[immunosuppression]]></category>
		<category><![CDATA[interferon]]></category>
		<category><![CDATA[liver transplant]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[ribavirin]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=2010</guid>
		<description><![CDATA[Immunosuppressive regimens initiated at the time of liver transplantation, as well as methods of treating acute cellular rejection during the post-transplant course, appear to have a significant role in the development of liver disease associated with HCV recurrence. Consequently, several strategies have emerged with the goal of minimizing the negative impact of high-dose or pulse [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-immunosuppression.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Management of Recurrent Hepatitis C Following Liver Transplantation: Predictors of Sustained Viral Clearance</title>
		<link>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-predictors-of-sustained-viral-clearance.html</link>
		<comments>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-predictors-of-sustained-viral-clearance.html#comments</comments>
		<pubDate>Sat, 07 Aug 2010 08:28:59 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[hepatitis С]]></category>
		<category><![CDATA[Hepatitis C virus]]></category>
		<category><![CDATA[immunosuppression]]></category>
		<category><![CDATA[interferon]]></category>
		<category><![CDATA[liver transplant]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[ribavirin]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=2007</guid>
		<description><![CDATA[Achievement of SVR in the setting of recurrent HCV following liver transplantation may have a major impact on long-term outcomes, including improved graft and patient survival. Identifying patients with a greater likelihood of achieving SVR is an important consider­ation in the selection of potential treatment candidates and is a key factor in developing strategies for [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-predictors-of-sustained-viral-clearance.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Management of Recurrent Hepatitis C Following Liver Transplantation: Antiviral Therapy</title>
		<link>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-antiviral-therapy.html</link>
		<comments>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-antiviral-therapy.html#comments</comments>
		<pubDate>Tue, 03 Aug 2010 16:58:58 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[hepatitis С]]></category>
		<category><![CDATA[Hepatitis C virus]]></category>
		<category><![CDATA[immunosuppression]]></category>
		<category><![CDATA[interferon]]></category>
		<category><![CDATA[liver transplant]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[ribavirin]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=2005</guid>
		<description><![CDATA[Treatment Before Transplantation Although PegIFN in combination with RBV remains the gold standard for the treatment of chronic HCV infec­tion in the pretransplant setting, long-term viral sup­pression can be achieved in only approximately one half of patients. Antiviral therapy in patients with HCV cirrhosis awaiting liver transplantation should be consid­ered in select individuals; however, poor [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/08/management-of-recurrent-hepatitis-c-following-liver-transplantation-antiviral-therapy.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Management of Recurrent Hepatitis C Following Liver Transplantation: Fibrosing Cholestatic Hepatitis C</title>
		<link>http://www.advances-in-medicine.com/2010/07/management-of-recurrent-hepatitis-c-following-liver-transplantation-fibrosing-cholestatic-hepatitis-c.html</link>
		<comments>http://www.advances-in-medicine.com/2010/07/management-of-recurrent-hepatitis-c-following-liver-transplantation-fibrosing-cholestatic-hepatitis-c.html#comments</comments>
		<pubDate>Fri, 30 Jul 2010 20:33:57 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[hepatitis С]]></category>
		<category><![CDATA[Hepatitis C virus]]></category>
		<category><![CDATA[immunosuppression]]></category>
		<category><![CDATA[interferon]]></category>
		<category><![CDATA[liver transplant]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[ribavirin]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=2003</guid>
		<description><![CDATA[Although it occurs in less than 10% of transplant recipients with chronic HCV, a severe and rapidly pro­gressive form of recurrent HCV infection characterized by cholestatic disease has a major impact on survival. In contrast to a chronic hepatitis observed in most patients with recurrent HCV, this syndrome is defined by a total serum bilirubin [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/07/management-of-recurrent-hepatitis-c-following-liver-transplantation-fibrosing-cholestatic-hepatitis-c.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Management of Recurrent Hepatitis C Following Liver Transplantation: Hepatitis C and the Transplanted Liver</title>
		<link>http://www.advances-in-medicine.com/2010/07/management-of-recurrent-hepatitis-c-following-liver-transplantation-hepatitis-c-and-the-transplanted-liver.html</link>
		<comments>http://www.advances-in-medicine.com/2010/07/management-of-recurrent-hepatitis-c-following-liver-transplantation-hepatitis-c-and-the-transplanted-liver.html#comments</comments>
		<pubDate>Sun, 25 Jul 2010 18:02:54 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[hepatitis С]]></category>
		<category><![CDATA[Hepatitis C virus]]></category>
		<category><![CDATA[immunosuppression]]></category>
		<category><![CDATA[interferon]]></category>
		<category><![CDATA[liver transplant]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[ribavirin]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=2001</guid>
		<description><![CDATA[Recurrence of Chronic Infection Recurrence of hepatitis C viremia following liver trans­plantation occurs in all patients with chronic HCV infec­tion who have detectable serum HCV RNA levels prior to transplant. A significant decline in serum HCV RNA levels has been observed during the anhepatic phase of transplantation and immediately following reperfusion of the allograft; however, [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/07/management-of-recurrent-hepatitis-c-following-liver-transplantation-hepatitis-c-and-the-transplanted-liver.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

